x
Filter:
Filters Applied
- Editorials
- Thakar, Charuhas VRemove Thakar, Charuhas V filter
Publication Date
Please choose a date range between 2017 and 2021.
Editorials
6 Results
- Editorial
Treatment of Diabetic Nephropathy: Changing Landscapes and New Horizons
Advances in Chronic Kidney DiseaseVol. 28Issue 4p279Published in issue: July, 2021- Charuhas V. Thakar
Cited in Scopus: 1Until the early 19th century, diabetes mellitus (DM) was regarded as a disease of the kidney, in which one of the signs was that of an increase in the volume of urine and wasting. Only after the identification of glucose in blood and urine in the late 18th century was it recognized as a metabolic disorder. It was noted in parallel that patients with DM may show presence of coagulable urine containing albumin as a sign of kidney disease. After the advent of availability of insulin in the early 1920s, which led to increased survival, diabetic nephropathy became more apparent. - Editorial
Dialysis: Please Try This at Home!
Advances in Chronic Kidney DiseaseVol. 28Issue 2p121–122Published in issue: March, 2021- Charuhas V. Thakar
Cited in Scopus: 0Yes, in 2021, we are able to say that the quality of life and freedom to do the things we love can be possible while on dialysis. A special mention to the photograph on the cover of this issue dedicated to home hemodialysis (see credits in the issue), which exemplifies that. - Editorial
Future of Nephrology Workforce: Reimagining Educational Value
Advances in Chronic Kidney DiseaseVol. 27Issue 4p277–278Published in issue: July, 2020- Charuhas V. Thakar
Cited in Scopus: 0The definition of this term states “people engaged in or available for work in any enterprise or company”. Should we be satisfied in simply creating the future workforce? Or should we redefine in how we even articulate what the future of our profession may look like? Should we not be raising the bar to say that we want to nurture the next generation of compassionate and astute clinicians, scientists, and leaders? If so, then we need to reimagine how to do that and tread with caution as we pass on the knowledge to that generation. - Editorial
Interventional Nephrology: What, Who, Why?
Advances in Chronic Kidney DiseaseVol. 27Issue 3p167Published in issue: May, 2020- Charuhas V. Thakar
Cited in Scopus: 0These 2 words can mean different things from a patient's or a provider's perspective. For the patient, it is a “lifeline” to undergo a life-sustaining treatment, day after day, and lack of an optimal access can literally be a death sentence. Whether be it lack of achieving or maintaining the vascular access. - Editorial
Toxicology and Kidney: Not so Innocent Bystander
Advances in Chronic Kidney DiseaseVol. 27Issue 1p1–2Published in issue: January, 2020- Charuhas V. Thakar
Cited in Scopus: 0Patients are exposed to numerous prescribed and over-the-counter medications. Unfortunately, drugs remain a relatively common cause of acute and chronic kidney injury. By some estimates, up to 1-in-3 cases of acute kidney injury (AKI) can be attributed to the effect of prescribed drugs and endogenous/exogenous toxins. However, establishing causality in drug-induced kidney disease is challenging and requires knowledge of the biological plausibility of the agent, mechanism of injury, time course, and assessment of competing risk factors. - Guest Editorial
Acute Kidney Injury: A Paradigm in Quality and Patient Safety
Advances in Chronic Kidney DiseaseVol. 24Issue 4p192–193Published in issue: July, 2017- Charuhas V. Thakar
Cited in Scopus: 0The first contemporary description of the syndrome of acute tubular necrosis (synonymously used with the clinical diagnosis of acute kidney injury) was reported by Drs. Bywaters and Beal.1 That specific case was a clinical description of a young woman who had suffered crush injuries during the “London Blitz,” with the probably cause of ATN resulting from a combination of ischemic injury and rhabdomyolysis. It turns out that there have been prior historical references hinting toward nephrotoxic injury.
